Through its ultramicronized form, Palmidrol exhibits inhibitory effects on tumors by suppressing colon cancer cell proliferation via the activation of peroxisome proliferator-activated receptor α (PPAR-α) and G protein-coupled receptor 55 (GPR55). Here, PPARA is linked to colonic neoplasm.